Literature DB >> 30031467

Imaging of Prostate Cancer Using 11C-Choline PET/Computed Tomography.

Paolo Castellucci1, Francesco Ceci2, Stefano Fanti1.   

Abstract

This article reviews the role of 11C-choline-PET/computed tomography (CT) in patients with prostate cancer for diagnosis, staging, and restaging the disease in case of biochemical recurrence after primary treatment. The main application of this imaging procedure is restaging of the disease in case of biochemical recurrence. 11C-Choline-PET/CT proved its value for metastases-directed salvage therapies and for monitoring therapy response in castration-resistant patients. Prostate-specific antigen and prostate-specific antigen kinetics values confirmed their correlation with 11C-choline PET/CT sensitivity.11C-CholinePET/CT, despite low sensitivity to stage disease or in case of biochemical failure with low PSA levels, has an important impact on the management of patients with prostate cancer.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Choline PET/CT; Diagnosis; Prostate cancer; Staging

Mesh：

Substances：

Year:  2018        PMID： 30031467     DOI： 10.1016/j.ucl.2018.03.007

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN： 0094-0143            Impact factor:   2.241


  3 in total

1.  [99Tc]Sestamibi bioaccumulation induces apoptosis in prostate cancer cells: an in vitro study.

Authors:  Nicoletta Urbano; Manuel Scimeca; Elena Bonanno; Rita Bonfiglio; Alessandro Mauriello; Orazio Schillaci
Journal:  Mol Cell Biochem       Date:  2022-05-07       Impact factor: 3.842

2.  18F-Fluoroethylcholine PET/CT Radiomic Analysis for Newly Diagnosed Prostate Cancer Patients: A Monocentric Study.

Authors:  Daniele Antonio Pizzuto; Elizabeth Katherine Anna Triumbari; David Morland; Luca Boldrini; Roberto Gatta; Giorgio Treglia; Riccardo Bientinesi; Marco De Summa; Marina De Risi; Carmelo Caldarella; Eros Scarciglia; Angelo Totaro; Salvatore Annunziata
Journal:  Int J Mol Sci       Date:  2022-08-14       Impact factor: 6.208

3.  The Role of [18F]Fluciclovine PET/CT in the Characterization of High-Risk Primary Prostate Cancer: Comparison with [11C]Choline PET/CT and Histopathological Analysis.

Authors:  Lucia Zanoni; Riccardo Mei; Lorenzo Bianchi; Francesca Giunchi; Lorenzo Maltoni; Cristian Vincenzo Pultrone; Cristina Nanni; Irene Bossert; Antonella Matti; Riccardo Schiavina; Michelangelo Fiorentino; Cristina Fonti; Filippo Lodi; Antonietta D'Errico; Eugenio Brunocilla; Stefano Fanti
Journal:  Cancers (Basel)       Date:  2021-03-29       Impact factor: 6.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.